EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Overexpression of diglucosyldiacylglycerol synthase leads to daptomycin resistance in Bacillus subtilis

Ryogo Yamamoto, Kazuya Ishikawa iD, Yusuke Miyoshi, Kazuyuki Furuta iD, Shin-Ichi Miyoshi, Chikara Kaito iD

Journal of Bacteriology · 24.10.2024 · 206 (10)

DOI: 10.1128/jb.00307-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Bacteriology, erschienen am 24.10.2024. Verfasst von Ryogo Yamamoto und 5 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan. Hauptthemen laut MEDLINE: Bacillus subtilis, Daptomycin, Drug Resistance, Bacterial, Anti-Bacterial Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MEXT | Japan Society for the Promotion of Science (JSPS), Japan Agency for Medical Research and Development (AMED), Takeda Science Foundation (TSF).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The lipopeptide antibiotic daptomycin exhibits bactericidal activity against Gram-positive bacteria by forming a complex with phosphatidylglycerol (PG) and lipid II in the cell membrane, causing membrane perforation. With the emergence of daptomycin-resistant bacteria, understanding the mechanisms of bacterial resistance to daptomycin has gained great importance. In this study, we aimed to identify the genetic factors contributing to daptomycin resistance in Bacillus subtilis , a model Gram-positive bacterium. Our findings demonstrated that overexpression of ugtP , which encodes diglucosyldiacylglycerol synthase, induces daptomycin resistance in B. subtilis . Specifically, overexpression of ugtP resulted in increased levels of diglucosyldiacylglycerol (Glc 2 DAG) and decreased levels of acidic phospholipids cardiolipin and PG, as well as the basic phospholipid lysylphosphatidylglycerol. However, ugtP overexpression did not alter the cell surface charge and the susceptibility to the cationic antimicrobial peptide nisin or the cationic surfactant hexadecyltrimethylammonium bromide. Furthermore, by serial passaging in the presence of daptomycin, we obtained daptomycin-resistant mutants carrying ugtP mutations. These mutants showed increased levels of Glc 2 DAG and a >4-fold increase in the minimum inhibitory concentration of daptomycin. These results suggest that increased Glc 2 DAG levels, driven by ugtP overexpression, modify the phospholipid composition and confer daptomycin resistance in B. subtilis without altering the cell surface charge of the bacteria. IMPORTANCE Daptomycin is one of the last-resort drugs for the treatment of methicillin-resistant Staphylococcus aureus infections, and the emergence of daptomycin-resistant bacteria has become a major concern. Understanding the mechanism of daptomycin resistance is important for establishing clinical countermeasures against daptomycin-resistant bacteria. In the present study, we found that overexpression of ugtP , which encodes diglucosyldiacylglycerol synthase, induces daptomycin resistance in B. subtilis , a model Gram-positive bacteria. The overexpression of UgtP increased diglucosyldiacylglycerol levels, resulting in altered phospholipid composition and daptomycin resistance. These findings are important for establishing clinical strategies against daptomycin-resistant bacteria, including their detection and management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bacillus subtilisDaptomycinDrug Resistance, BacterialAnti-Bacterial AgentsBacterial ProteinsMicrobial Sensitivity TestsGene Expression Regulation, BacterialPhosphatidylglycerols

Stichwörter der Autor:innen

daptomycindiglucosyldiacylglycerolphospholipid

Substanzen

DaptomycinAnti-Bacterial AgentsBacterial ProteinsPhosphatidylglycerols

Autor:innen und Institutionen

  • Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
  • Research Center for Intestinal Health Science, Okayama University, Okayama, Japan.

ORCID-Profile: Kazuya Ishikawa, Kazuyuki Furuta, Chikara Kaito

Förderung

  • MEXT | Japan Society for the Promotion of Science (JSPS)
  • Japan Agency for Medical Research and Development (AMED)
  • Takeda Science Foundation (TSF)
  • Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care (Ichiro Kanehara Foundation)
  • Ryobi Teien Memory Foundation (Ryobi Teien Memorial Foundation)

Zitieren

APA

Yamamoto, R., Ishikawa, K., Miyoshi, Y., Furuta, K., Miyoshi, S. I., & Kaito, C. (2024). Overexpression of diglucosyldiacylglycerol synthase leads to daptomycin resistance in Bacillus subtilis. Journal of Bacteriology, 206(10). https://doi.org/10.1128/jb.00307-24

Vancouver

Yamamoto R, Ishikawa K, Miyoshi Y, Furuta K, Miyoshi SI, Kaito C. Overexpression of diglucosyldiacylglycerol synthase leads to daptomycin resistance in Bacillus subtilis. Journal of Bacteriology. 2024;206(10). doi:10.1128/jb.00307-24

BibTeX
@article{Yamamoto2024,
  author = {Yamamoto, Ryogo and Ishikawa, Kazuya and Miyoshi, Yusuke and Furuta, Kazuyuki and Miyoshi, Shin-Ichi and Kaito, Chikara},
  title = {Overexpression of diglucosyldiacylglycerol synthase leads to daptomycin resistance in Bacillus subtilis},
  journal = {Journal of Bacteriology},
  year = {2024},
  volume = {206},
  number = {10},
  doi = {10.1128/jb.00307-24}
}
Kostenlos starten →